Lv1
4 积分 2022-09-01 加入
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins
16小时前
已完结
In vivo human T cell engineering with enveloped delivery vehicles
18小时前
已完结
Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations
7天前
已完结
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells
23天前
已完结
A new method for purification of recombinant human α-synuclein in Escherichia coli
26天前
已完结
In vivo CAR engineering for immunotherapy
1个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
1个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Design of highly functional genome editors by modelling CRISPR–Cas sequences
2个月前
已完结
Trends in the development of cellular and gene therapy in China
2个月前
已完结
皖公网安备34019202002308
